Business: Genetic Technologies is a global molecular diagnostic business with an extensive range of international patents and a portfolio of tests and related services. Their aim is simple: to concentrate on markets where they can establish a long-term dominant position by providing tests that genuinely affect clinical outcomes. They are already the leading non-government genetic testing business in Australia, and through their wholly owned subsidiary Phenogen Sciences, they now have a solid and growing presence in the USA. They remain committed to the development of a global portfolio of cancer management tests. The first of which is the Breast Cancer Risk Assessment Test, BREVAGenTM.